BioCardia, Inc.BCDANASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank36
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P36
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -1.39% |
| Q2 2025 | -1.92% |
| Q1 2025 | 37.12% |
| Q4 2024 | 1.46% |
| Q3 2024 | -99.01% |
| Q2 2024 | 14.25% |
| Q1 2024 | 17.34% |
| Q4 2023 | 23.26% |
| Q3 2023 | 23.45% |
| Q2 2023 | -23.09% |
| Q1 2023 | 14.58% |
| Q4 2022 | -49.40% |
| Q3 2022 | 24.16% |
| Q2 2022 | 9.20% |
| Q1 2022 | 2.08% |
| Q4 2021 | -12.56% |
| Q3 2021 | 7.75% |
| Q2 2021 | -52.15% |
| Q1 2021 | 44.89% |
| Q4 2020 | 8.12% |
| Q3 2020 | -66.92% |
| Q2 2020 | 25.56% |
| Q1 2020 | 8.08% |
| Q4 2019 | -121.20% |
| Q3 2019 | 34.64% |
| Q2 2019 | 8.64% |
| Q1 2019 | 24.06% |
| Q4 2018 | -61.57% |
| Q3 2018 | 27.68% |
| Q2 2018 | 8.50% |
| Q1 2018 | -20.24% |
| Q4 2017 | -42.09% |
| Q3 2017 | 15.02% |
| Q2 2017 | 8.21% |
| Q1 2017 | 79.51% |
| Q4 2016 | -299.80% |
| Q3 2016 | 10600.00% |
| Q2 2016 | -162.35% |
| Q1 2016 | -25.44% |
| Q4 2015 | 200.00% |